Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  InMode Ltd.    INMD   IL0011595993

INMODE LTD.

(INMD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/23/2020 11/24/2020 11/25/2020 11/27/2020 11/30/2020 Date
43.1(c) 43.29(c) 43.59(c) 43.72(c) 43.08(c) Last
464 596 524 401 588 289 228 169 466 696 Volume
+0.26% +0.44% +0.69% +0.30% -1.46% Change
More quotes
Financials (USD)
Sales 2020 195 M - -
Net income 2020 61,3 M - -
Net cash position 2020 295 M - -
P/E ratio 2020 29,4x
Yield 2020 -
Sales 2021 245 M - -
Net income 2021 81,7 M - -
Net cash position 2021 476 M - -
P/E ratio 2021 22,4x
Yield 2021 -
Capitalization 1 534 M 1 534 M -
EV / Sales 2020 6,36x
EV / Sales 2021 4,32x
Nbr of Employees 251
Free-Float 57,6%
More Financials
Company
Inmode Ltd is an Israel-based company. It designs, develops, manufactures and commercializes energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. The Company’s proprietary technologies are used by physicians to remodel subdermal adipose, or fatty, tissue in a variety of procedures including fat reduction with simultaneous skin tightening, face and body contouring and ablative skin... 
More about the company
Notations Surperformance© of InMode Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about INMODE LTD.
11/12INMODE : 3Q Earnings Snapshot
AQ
11/12INMODE : Reports Record Third Quarter 2020 Financial Results; Quarterly Revenues..
PR
11/11NANOWEAR : Receives FDA 510(k) Clearance for SimpleSENSE, a Cloth-Based Wearable..
PR
11/02INMODE : to Present at Upcoming Virtual Investor Conferences in November
PR
10/20INMODE : Introduces Morpheus8 Body Multi-pulse Burst Technology
PR
10/13INMODE : Expects Record Third Quarter Results, Revenues Between $59.2-$59.5M, No..
PR
08/05INMODE : 2Q Earnings Snapshot
AQ
08/05INMODE : Reports Second Quarter 2020 Financial Results; Quarterly Revenues of $3..
PR
08/03INMODE : to Present at Upcoming Virtual Conferences in August
PR
07/27INMODE : Technologies Win Major Beauty Awards
PR
07/13INMODE : to Report Second Quarter 2020 Financial Results on August 5, 2020; Mana..
PR
07/06INMODE : Announces NMPA (formerly CFDA) Approval for Two InMode Platforms in Chi..
PR
07/02Elizabeth Tallett Joins Moderna's Board of Directors
AQ
06/16INMODE : Receives Health Canada Certification for Evolve Tone
PR
05/11INMODE : to Participate at Upcoming Virtual Investor Conferences
PR
More news
News in other languages on INMODE LTD.

- No features available -

More news
Chart INMODE LTD.
Duration : Period :
InMode Ltd. Technical Analysis Chart | INMD | IL0011595993 | MarketScreener
Technical analysis trends INMODE LTD.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 53,33 $
Last Close Price 43,08 $
Spread / Highest target 34,6%
Spread / Average Target 23,8%
Spread / Lowest Target 18,4%
EPS Revisions
Managers
NameTitle
Moshe Mizrahy Chairman & Chief Executive Officer
Yair Malca Chief Financial Officer
Michael Kreindel Chief Technology Officer & Director
Spero Theodorou Chief Medical Officer
Hadar Ron Director
Sector and Competitors
1st jan.Capitalization (M$)
INMODE LTD.11.53%1 557
THERMO FISHER SCIENTIFIC39.56%179 698
DANAHER CORPORATION41.24%153 996
INTUITIVE SURGICAL, INC.23.46%85 794
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.83.50%62 582
EDWARDS LIFESCIENCES CORPORATION9.64%53 138